ArticleFrontiers in immunology2024

Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study.

Patrick-Pascal Strunz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.